Table1.

Clinical characteristics CAF and gastric cancer survival in TCGA cohort

Variates		Cases	Univariate HR 95% CI (P Value)		Multivariate HR 95%CI (P value)
			OS	DFS	OS	DFS
Age	< 50(ref)	20
	50	219	0.5409–4.15 (0.437)	0.35–2.25 (0.798)	0.55–4.39 (0.4116)	0.35–2.33 (0.8790)
sex	Female(ref)	94
	male	145	0.68–2.03 (0.562)	0.98–3.87 (0.0557)	0.67–2.03 (0.5917)	1.02–4.05 (0.0440)
Lauren classification	Intestinal(ref)	99
	Diffuse	44	0.61–2.57 (0.538)	0.80–4.18 (0.1686)	0.52–2.35 (0.7959)	0.65–3.76 (0.3134)
	NOS	95	0.93–3.03 (0.088)	1.17–4.86 (0.0163)	0.81–2.80 (0.1966)	1.07–4.73 (0.0329)
Stage	I/II(ref)	138
	III	101	0.95–2.71 (0.0783)	0.58–1.91 (0.866)	1.02–3.00 (0.0420)	0.62–2.06 (0.7085)
CAF	Low(ref)	73
	Medium	81	1.04–4.66 (0.0389)	0.67–3.66 (0.3037)	0.97–4.57 (0.0591)	0.54–3.10 (0.5632)
	High	85	1.09–4.73 (0.0285)	1.04–4.91 (0.0398)	1.04–4.71 (0.0391)	0.87–4.24 (0.1081)

OS overall survival, DFS disease-free survival, 95%CI: 95% confidence interval